Alaunos Therapeutics, Inc.
TCRT
$2.21
$0.3216.93%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 16.89% | -92.30% | -82.00% | -85.91% | -86.55% |
Total Receivables | -50.00% | 100.00% | 400.00% | -- | 0.00% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -61.24% | -60.55% | -24.52% | 101.84% | 383.81% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -20.09% | -82.33% | -66.65% | -72.41% | -75.09% |
|
|||||
Total Current Assets | -20.09% | -82.33% | -66.65% | -72.41% | -75.09% |
Net Property, Plant & Equipment | -- | -- | -100.00% | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 1.22% | -64.88% | -66.66% | -81.74% | -83.25% |
|
|||||
Total Accounts Payable | 121.64% | 39.20% | -16.23% | -64.71% | -75.32% |
Total Accrued Expenses | -51.11% | -64.07% | -86.87% | -88.02% | -83.24% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 18.41% | -14.35% | -64.62% | -82.34% | -82.05% |
|
|||||
Total Current Liabilities | 18.41% | -14.35% | -64.62% | -82.34% | -82.05% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 18.41% | -14.35% | -64.62% | -85.09% | -85.55% |
|
|||||
Common Stock & APIC | 0.42% | 0.04% | 0.05% | 0.07% | 0.14% |
Retained Earnings | -0.43% | -0.44% | -0.51% | -1.30% | -2.13% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -2.92% | -77.94% | -67.29% | -80.40% | -82.58% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -2.92% | -77.94% | -67.29% | -80.40% | -82.58% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -2.92% | -77.94% | -67.29% | -80.40% | -82.58% |
|